id,target_name,id_chembl,indication,probability,model_accuracy,inchikey_id
43,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.55,98.95,ACHIMAQPWZMJAP-UHFFFAOYSA-N
44,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.55,98.95,ACHIMAQPWZMJAP-UHFFFAOYSA-N
45,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
46,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
47,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
48,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
49,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],88.07,99.23,ACHIMAQPWZMJAP-UHFFFAOYSA-N
50,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],88.07,99.23,ACHIMAQPWZMJAP-UHFFFAOYSA-N
51,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.09,98.95,ABIJFSBIBFNXES-UHFFFAOYSA-N
52,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.09,98.95,ABIJFSBIBFNXES-UHFFFAOYSA-N
53,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],81.19,99.23,ABIJFSBIBFNXES-UHFFFAOYSA-N
54,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],81.19,99.23,ABIJFSBIBFNXES-UHFFFAOYSA-N
55,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],97.2,98.95,AADNGOQDWPOULN-UHFFFAOYSA-N
56,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],97.2,98.95,AADNGOQDWPOULN-UHFFFAOYSA-N
57,Xanthine dehydrogenase,T40954,Encephalopathy [ICD-11: 8E47],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
58,Xanthine dehydrogenase,T40954,Gout [ICD-11: FA25],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
59,Xanthine dehydrogenase,T40954,Heart failure [ICD-11: BD10-BD13],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
60,Xanthine dehydrogenase,T40954,Hyperuricaemia [ICD-11: 5C55.Y],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
61,Xanthine dehydrogenase,T40954,Solid tumour/cancer [ICD-11: 2A00-2F9Z],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
62,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
63,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
64,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
65,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
66,Methionine aminopeptidase 2,T75596,Autoimmune diabetes [ICD-11: 5A10],80.17,97.28,AADNGOQDWPOULN-UHFFFAOYSA-N
67,Methionine aminopeptidase 2,T75596,Obesity [ICD-11: 5B81],80.17,97.28,AADNGOQDWPOULN-UHFFFAOYSA-N
68,Methionine aminopeptidase 2,T75596,Solid tumour/cancer [ICD-11: 2A00-2F9Z],80.17,97.28,AADNGOQDWPOULN-UHFFFAOYSA-N
69,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],97.45,98.95,ABFGLANSNTWKHS-UHFFFAOYSA-N
70,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],97.45,98.95,ABFGLANSNTWKHS-UHFFFAOYSA-N
71,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
72,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
73,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
74,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
75,Estrogen receptor beta,T80896,Alzheimer disease [ICD-11: 8A20],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
76,Estrogen receptor beta,T80896,Breast cancer [ICD-11: 2C60-2C65],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
77,Estrogen receptor beta,T80896,Carcinoma [ICD-11: 2A00-2F9Z],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
78,Estrogen receptor beta,T80896,Cushing disease [ICD-11: 5A70],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
79,Estrogen receptor beta,T80896,Estrogen deficiency [ICD-11: FB83.0Y],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
80,Estrogen receptor beta,T80896,Hepatitis virus infection [ICD-11: 1E50-1E51],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
81,Estrogen receptor beta,T80896,Hot flushes [ICD-11: GA30],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
82,Estrogen receptor beta,T80896,Hyperlipidaemia [ICD-11: 5C80],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
83,Estrogen receptor beta,T80896,Inflammation [ICD-11: 1A00-CA43.1],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
84,Estrogen receptor beta,T80896,Inflammatory bowel disease [ICD-11: DD72],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
85,Estrogen receptor beta,T80896,Irregularities [ICD-11: N.A.],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
86,Estrogen receptor beta,T80896,Menopause symptom [ICD-11: GA30.0],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
87,Estrogen receptor beta,T80896,Ocular disease [ICD-11: 1F00.1Z],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
88,Estrogen receptor beta,T80896,Prostate cancer [ICD-11: 2C82.0],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
89,Estrogen receptor beta,T80896,Prostate hyperplasia [ICD-11: GA90],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
90,Estrogen receptor beta,T80896,Sepsis [ICD-11: 1G40-1G41],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
91,Estrogen receptor beta,T80896,Thrombocytopenia [ICD-11: 3B64],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
92,Estrogen receptor beta,T80896,Trematode infection [ICD-11: 1F8Y],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
93,Estrogen receptor beta,T80896,Vasomotor symptom [ICD-11: CA08],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
94,Methionine aminopeptidase 2,T75596,Autoimmune diabetes [ICD-11: 5A10],88.25,97.28,ABFGLANSNTWKHS-UHFFFAOYSA-N
95,Methionine aminopeptidase 2,T75596,Obesity [ICD-11: 5B81],88.25,97.28,ABFGLANSNTWKHS-UHFFFAOYSA-N
96,Methionine aminopeptidase 2,T75596,Solid tumour/cancer [ICD-11: 2A00-2F9Z],88.25,97.28,ABFGLANSNTWKHS-UHFFFAOYSA-N
97,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],98.15,98.95,AAYULPZFZMTHED-UHFFFAOYSA-N
98,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],98.15,98.95,AAYULPZFZMTHED-UHFFFAOYSA-N
99,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
100,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
101,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
102,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
103,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],98.88,98.95,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
104,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],98.88,98.95,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
105,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
106,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
107,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
108,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
109,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.53,98.95,ABKIZJIYYYJWPR-UHFFFAOYSA-N
110,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.53,98.95,ABKIZJIYYYJWPR-UHFFFAOYSA-N
111,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
112,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
113,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
114,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
115,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],81.78,99.23,ABKIZJIYYYJWPR-UHFFFAOYSA-N
116,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],81.78,99.23,ABKIZJIYYYJWPR-UHFFFAOYSA-N
117,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],97.16,98.95,ACKVRMKWDURAQD-UHFFFAOYSA-N
118,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],97.16,98.95,ACKVRMKWDURAQD-UHFFFAOYSA-N
119,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
120,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
121,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
122,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
123,Cystic fibrosis transmembrane conductance regulator,T55654,Acute lung injury [ICD-11: NB32.3],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
124,Cystic fibrosis transmembrane conductance regulator,T55654,Cystic fibrosis [ICD-11: CA25],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
125,Cystic fibrosis transmembrane conductance regulator,T55654,Diarrhea [ICD-11: ME05.1],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
126,Cystic fibrosis transmembrane conductance regulator,T55654,HIV-associated diarrhoea [ICD-11: 1A2Z],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
127,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],95.11,98.95,ABIDTPIPXGGOOI-UHFFFAOYSA-N
128,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],95.11,98.95,ABIDTPIPXGGOOI-UHFFFAOYSA-N
129,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
130,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
131,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
132,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
133,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],82.72,99.23,ABIDTPIPXGGOOI-UHFFFAOYSA-N
134,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],82.72,99.23,ABIDTPIPXGGOOI-UHFFFAOYSA-N
135,Estrogen receptor beta,T80896,Alzheimer disease [ICD-11: 8A20],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
136,Estrogen receptor beta,T80896,Breast cancer [ICD-11: 2C60-2C65],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
137,Estrogen receptor beta,T80896,Carcinoma [ICD-11: 2A00-2F9Z],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
138,Estrogen receptor beta,T80896,Cushing disease [ICD-11: 5A70],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
139,Estrogen receptor beta,T80896,Estrogen deficiency [ICD-11: FB83.0Y],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
140,Estrogen receptor beta,T80896,Hepatitis virus infection [ICD-11: 1E50-1E51],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
141,Estrogen receptor beta,T80896,Hot flushes [ICD-11: GA30],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
142,Estrogen receptor beta,T80896,Hyperlipidaemia [ICD-11: 5C80],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
143,Estrogen receptor beta,T80896,Inflammation [ICD-11: 1A00-CA43.1],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
144,Estrogen receptor beta,T80896,Inflammatory bowel disease [ICD-11: DD72],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
145,Estrogen receptor beta,T80896,Irregularities [ICD-11: N.A.],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
146,Estrogen receptor beta,T80896,Menopause symptom [ICD-11: GA30.0],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
147,Estrogen receptor beta,T80896,Ocular disease [ICD-11: 1F00.1Z],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
148,Estrogen receptor beta,T80896,Prostate cancer [ICD-11: 2C82.0],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
149,Estrogen receptor beta,T80896,Prostate hyperplasia [ICD-11: GA90],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
150,Estrogen receptor beta,T80896,Sepsis [ICD-11: 1G40-1G41],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
151,Estrogen receptor beta,T80896,Thrombocytopenia [ICD-11: 3B64],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
152,Estrogen receptor beta,T80896,Trematode infection [ICD-11: 1F8Y],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
153,Estrogen receptor beta,T80896,Vasomotor symptom [ICD-11: CA08],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
154,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.28,98.95,ABDQTIKKAYGHNV-UHFFFAOYSA-N
155,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.28,98.95,ABDQTIKKAYGHNV-UHFFFAOYSA-N
156,Xanthine dehydrogenase,T40954,Encephalopathy [ICD-11: 8E47],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
157,Xanthine dehydrogenase,T40954,Gout [ICD-11: FA25],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
158,Xanthine dehydrogenase,T40954,Heart failure [ICD-11: BD10-BD13],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
159,Xanthine dehydrogenase,T40954,Hyperuricaemia [ICD-11: 5C55.Y],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
160,Xanthine dehydrogenase,T40954,Solid tumour/cancer [ICD-11: 2A00-2F9Z],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
161,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],89.41,99.23,ABDQTIKKAYGHNV-UHFFFAOYSA-N
162,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],89.41,99.23,ABDQTIKKAYGHNV-UHFFFAOYSA-N
163,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
164,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
165,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
166,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
167,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.55,98.95,ACHIMAQPWZMJAP-UHFFFAOYSA-N
168,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.55,98.95,ACHIMAQPWZMJAP-UHFFFAOYSA-N
169,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
170,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
171,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
172,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],94.99,99.15,ACHIMAQPWZMJAP-UHFFFAOYSA-N
173,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],88.07,99.23,ACHIMAQPWZMJAP-UHFFFAOYSA-N
174,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],88.07,99.23,ACHIMAQPWZMJAP-UHFFFAOYSA-N
175,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.09,98.95,ABIJFSBIBFNXES-UHFFFAOYSA-N
176,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.09,98.95,ABIJFSBIBFNXES-UHFFFAOYSA-N
177,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],81.19,99.23,ABIJFSBIBFNXES-UHFFFAOYSA-N
178,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],81.19,99.23,ABIJFSBIBFNXES-UHFFFAOYSA-N
179,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],97.2,98.95,AADNGOQDWPOULN-UHFFFAOYSA-N
180,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],97.2,98.95,AADNGOQDWPOULN-UHFFFAOYSA-N
181,Xanthine dehydrogenase,T40954,Encephalopathy [ICD-11: 8E47],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
182,Xanthine dehydrogenase,T40954,Gout [ICD-11: FA25],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
183,Xanthine dehydrogenase,T40954,Heart failure [ICD-11: BD10-BD13],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
184,Xanthine dehydrogenase,T40954,Hyperuricaemia [ICD-11: 5C55.Y],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
185,Xanthine dehydrogenase,T40954,Solid tumour/cancer [ICD-11: 2A00-2F9Z],93.51,96.12,AADNGOQDWPOULN-UHFFFAOYSA-N
186,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
187,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
188,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
189,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],86.89,99.15,AADNGOQDWPOULN-UHFFFAOYSA-N
190,Methionine aminopeptidase 2,T75596,Autoimmune diabetes [ICD-11: 5A10],80.17,97.28,AADNGOQDWPOULN-UHFFFAOYSA-N
191,Methionine aminopeptidase 2,T75596,Obesity [ICD-11: 5B81],80.17,97.28,AADNGOQDWPOULN-UHFFFAOYSA-N
192,Methionine aminopeptidase 2,T75596,Solid tumour/cancer [ICD-11: 2A00-2F9Z],80.17,97.28,AADNGOQDWPOULN-UHFFFAOYSA-N
193,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],97.45,98.95,ABFGLANSNTWKHS-UHFFFAOYSA-N
194,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],97.45,98.95,ABFGLANSNTWKHS-UHFFFAOYSA-N
195,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
196,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
197,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
198,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],90.45,99.15,ABFGLANSNTWKHS-UHFFFAOYSA-N
199,Estrogen receptor beta,T80896,Alzheimer disease [ICD-11: 8A20],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
200,Estrogen receptor beta,T80896,Breast cancer [ICD-11: 2C60-2C65],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
201,Estrogen receptor beta,T80896,Carcinoma [ICD-11: 2A00-2F9Z],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
202,Estrogen receptor beta,T80896,Cushing disease [ICD-11: 5A70],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
203,Estrogen receptor beta,T80896,Estrogen deficiency [ICD-11: FB83.0Y],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
204,Estrogen receptor beta,T80896,Hepatitis virus infection [ICD-11: 1E50-1E51],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
205,Estrogen receptor beta,T80896,Hot flushes [ICD-11: GA30],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
206,Estrogen receptor beta,T80896,Hyperlipidaemia [ICD-11: 5C80],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
207,Estrogen receptor beta,T80896,Inflammation [ICD-11: 1A00-CA43.1],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
208,Estrogen receptor beta,T80896,Inflammatory bowel disease [ICD-11: DD72],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
209,Estrogen receptor beta,T80896,Irregularities [ICD-11: N.A.],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
210,Estrogen receptor beta,T80896,Menopause symptom [ICD-11: GA30.0],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
211,Estrogen receptor beta,T80896,Ocular disease [ICD-11: 1F00.1Z],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
212,Estrogen receptor beta,T80896,Prostate cancer [ICD-11: 2C82.0],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
213,Estrogen receptor beta,T80896,Prostate hyperplasia [ICD-11: GA90],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
214,Estrogen receptor beta,T80896,Sepsis [ICD-11: 1G40-1G41],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
215,Estrogen receptor beta,T80896,Thrombocytopenia [ICD-11: 3B64],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
216,Estrogen receptor beta,T80896,Trematode infection [ICD-11: 1F8Y],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
217,Estrogen receptor beta,T80896,Vasomotor symptom [ICD-11: CA08],90.43,98.35,ABFGLANSNTWKHS-UHFFFAOYSA-N
218,Methionine aminopeptidase 2,T75596,Autoimmune diabetes [ICD-11: 5A10],88.25,97.28,ABFGLANSNTWKHS-UHFFFAOYSA-N
219,Methionine aminopeptidase 2,T75596,Obesity [ICD-11: 5B81],88.25,97.28,ABFGLANSNTWKHS-UHFFFAOYSA-N
220,Methionine aminopeptidase 2,T75596,Solid tumour/cancer [ICD-11: 2A00-2F9Z],88.25,97.28,ABFGLANSNTWKHS-UHFFFAOYSA-N
221,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],98.15,98.95,AAYULPZFZMTHED-UHFFFAOYSA-N
222,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],98.15,98.95,AAYULPZFZMTHED-UHFFFAOYSA-N
223,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
224,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
225,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
226,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],82.52,99.15,AAYULPZFZMTHED-UHFFFAOYSA-N
227,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],98.88,98.95,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
228,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],98.88,98.95,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
229,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
230,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
231,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
232,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],85.94,99.15,ACNVUFYFWVZSGZ-UHFFFAOYSA-N
233,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.53,98.95,ABKIZJIYYYJWPR-UHFFFAOYSA-N
234,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.53,98.95,ABKIZJIYYYJWPR-UHFFFAOYSA-N
235,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
236,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
237,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
238,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],93.31,99.15,ABKIZJIYYYJWPR-UHFFFAOYSA-N
239,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],81.78,99.23,ABKIZJIYYYJWPR-UHFFFAOYSA-N
240,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],81.78,99.23,ABKIZJIYYYJWPR-UHFFFAOYSA-N
241,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],97.16,98.95,ACKVRMKWDURAQD-UHFFFAOYSA-N
242,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],97.16,98.95,ACKVRMKWDURAQD-UHFFFAOYSA-N
243,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
244,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
245,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
246,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],89.68,99.15,ACKVRMKWDURAQD-UHFFFAOYSA-N
247,Cystic fibrosis transmembrane conductance regulator,T55654,Acute lung injury [ICD-11: NB32.3],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
248,Cystic fibrosis transmembrane conductance regulator,T55654,Cystic fibrosis [ICD-11: CA25],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
249,Cystic fibrosis transmembrane conductance regulator,T55654,Diarrhea [ICD-11: ME05.1],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
250,Cystic fibrosis transmembrane conductance regulator,T55654,HIV-associated diarrhoea [ICD-11: 1A2Z],81.99,95.71,ACKVRMKWDURAQD-UHFFFAOYSA-N
251,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],95.11,98.95,ABIDTPIPXGGOOI-UHFFFAOYSA-N
252,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],95.11,98.95,ABIDTPIPXGGOOI-UHFFFAOYSA-N
253,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
254,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
255,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
256,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],86.6,99.15,ABIDTPIPXGGOOI-UHFFFAOYSA-N
257,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],82.72,99.23,ABIDTPIPXGGOOI-UHFFFAOYSA-N
258,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],82.72,99.23,ABIDTPIPXGGOOI-UHFFFAOYSA-N
259,Estrogen receptor beta,T80896,Alzheimer disease [ICD-11: 8A20],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
260,Estrogen receptor beta,T80896,Breast cancer [ICD-11: 2C60-2C65],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
261,Estrogen receptor beta,T80896,Carcinoma [ICD-11: 2A00-2F9Z],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
262,Estrogen receptor beta,T80896,Cushing disease [ICD-11: 5A70],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
263,Estrogen receptor beta,T80896,Estrogen deficiency [ICD-11: FB83.0Y],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
264,Estrogen receptor beta,T80896,Hepatitis virus infection [ICD-11: 1E50-1E51],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
265,Estrogen receptor beta,T80896,Hot flushes [ICD-11: GA30],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
266,Estrogen receptor beta,T80896,Hyperlipidaemia [ICD-11: 5C80],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
267,Estrogen receptor beta,T80896,Inflammation [ICD-11: 1A00-CA43.1],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
268,Estrogen receptor beta,T80896,Inflammatory bowel disease [ICD-11: DD72],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
269,Estrogen receptor beta,T80896,Irregularities [ICD-11: N.A.],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
270,Estrogen receptor beta,T80896,Menopause symptom [ICD-11: GA30.0],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
271,Estrogen receptor beta,T80896,Ocular disease [ICD-11: 1F00.1Z],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
272,Estrogen receptor beta,T80896,Prostate cancer [ICD-11: 2C82.0],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
273,Estrogen receptor beta,T80896,Prostate hyperplasia [ICD-11: GA90],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
274,Estrogen receptor beta,T80896,Sepsis [ICD-11: 1G40-1G41],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
275,Estrogen receptor beta,T80896,Thrombocytopenia [ICD-11: 3B64],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
276,Estrogen receptor beta,T80896,Trematode infection [ICD-11: 1F8Y],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
277,Estrogen receptor beta,T80896,Vasomotor symptom [ICD-11: CA08],80.31,98.35,ABIDTPIPXGGOOI-UHFFFAOYSA-N
278,Cathepsin D,T67102,Hypertension [ICD-11: BA00-BA04],96.28,98.95,ABDQTIKKAYGHNV-UHFFFAOYSA-N
279,Cathepsin D,T67102,Multiple sclerosis [ICD-11: 8A40],96.28,98.95,ABDQTIKKAYGHNV-UHFFFAOYSA-N
280,Xanthine dehydrogenase,T40954,Encephalopathy [ICD-11: 8E47],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
281,Xanthine dehydrogenase,T40954,Gout [ICD-11: FA25],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
282,Xanthine dehydrogenase,T40954,Heart failure [ICD-11: BD10-BD13],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
283,Xanthine dehydrogenase,T40954,Hyperuricaemia [ICD-11: 5C55.Y],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
284,Xanthine dehydrogenase,T40954,Solid tumour/cancer [ICD-11: 2A00-2F9Z],95.4,96.12,ABDQTIKKAYGHNV-UHFFFAOYSA-N
285,Casein kinase II alpha/beta,T51565,Cholangiocarcinoma [ICD-11: 2C12.10],89.41,99.23,ABDQTIKKAYGHNV-UHFFFAOYSA-N
286,Casein kinase II alpha/beta,T51565,Solid tumour/cancer [ICD-11: 2A00-2F9Z],89.41,99.23,ABDQTIKKAYGHNV-UHFFFAOYSA-N
287,Thyroid hormone receptor alpha,T79591,Congestive heart failure [ICD-11: BD10],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
288,Thyroid hormone receptor alpha,T79591,High blood cholesterol level [ICD-11: 5C80.00],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
289,Thyroid hormone receptor alpha,T79591,Hypothyroidism [ICD-11: 5A00],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
290,Thyroid hormone receptor alpha,T79591,Wound healing [ICD-11: EL8Y],87.41,99.15,ABDQTIKKAYGHNV-UHFFFAOYSA-N
291,,,,,,
